Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
How to use scorecard? Learn more
—
—
—
Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas.
Customise key metrics, see detailed forecasts, download stock data and more
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power". | Download
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power". | Download
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant